Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function.

"CONFLICT OF INTEREST M. Arfan Ikram is an Editorial Board Member of this journal but was not involved in the peer-review process nor had access to any information regarding its peer-review. All other authors have no conflict of interest to report."

"FUNDING The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The Netherlands Consortium of Dementia Cohorts (NCDC) is funded in the context of DeltaplanDementie from ZonMw Memorabel and Alzheimer Nederland (project number 73305095005). This work is part of the Heart-Brain Connection crossroads (HBCx) consortium of the Dutch CardioVascular Alliance (DCVA). HBCx has received funding from the Dutch Heart Foundation under grant agreements 2018-28 and CVON 2012-06. Dr. Bos is supported by a grant (A2017424F) from the BrightFocus Foundation and a grant from the Alzheimer’s Association (AARG-21-846504)."

"The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study Personal Registration Data collection is filed with the Erasmus MC Data Protection Officer under registration number EMC1712001. The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; https://www.trialregister.nl) and into the WHO International Clinical Trials Registry Platform (ICTRP; https://apps.who.int/trialsearch/) under shared catalogue number NL6645/NTR6831. All participants provided written informed consent to participate in the study and to have their information obtained from treating physicians."